179 related articles for article (PubMed ID: 16498366)
1. The management of severe vaginal obstruction from genital chronic graft-versus-host disease: diagnosis, surgical technique and follow-up.
Costantini S; Di Capua E; Bosi S; Chiodi S; Spinelli S
Minerva Ginecol; 2006 Feb; 58(1):11-6. PubMed ID: 16498366
[TBL] [Abstract][Full Text] [Related]
2. Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management.
Zantomio D; Grigg AP; MacGregor L; Panek-Hudson Y; Szer J; Ayton R
Bone Marrow Transplant; 2006 Oct; 38(8):567-72. PubMed ID: 16953208
[TBL] [Abstract][Full Text] [Related]
3. Complete vaginal obstruction with hematometra after hematopoietic stem cell transplantation for chronic myeloid leukemia: a case report.
Rodolakis A; Thomakos N; Harhalakis N; Iconomou T; Antsaklis A
J Reprod Med; 2007 Oct; 52(10):959-61. PubMed ID: 17977175
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment.
Spiryda LB; Laufer MR; Soiffer RJ; Antin JA
Biol Blood Marrow Transplant; 2003 Dec; 9(12):760-5. PubMed ID: 14677115
[TBL] [Abstract][Full Text] [Related]
5. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.
Spinelli S; Chiodi S; Costantini S; Van Lint MT; Raiola AM; Ravera GB; Bacigalupo A
Haematologica; 2003 Oct; 88(10):1163-8. PubMed ID: 14555313
[TBL] [Abstract][Full Text] [Related]
6. Female genital chronic graft-versus-host disease: importance of early diagnosis to avoid severe complications.
Hirsch P; Leclerc M; Rybojad M; Petropoulou AD; Robin M; Ribaud P; de la Tour RP; Cavelier-Balloy B; Socié G; Vexiau-Robert D
Transplantation; 2012 Jun; 93(12):1265-9. PubMed ID: 22466789
[TBL] [Abstract][Full Text] [Related]
7. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
[TBL] [Abstract][Full Text] [Related]
8. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
Lin Q; Dong M; Wang QM; Wen JY; Wu XY
Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
[TBL] [Abstract][Full Text] [Related]
9. Severe acute gastrointestinal graft-vs-host disease: an emerging surgical dilemma in contemporary cancer care.
Irani JL; Cutler CS; Whang EE; Clancy TE; Russell S; Swanson RS; Ashley SW; Zinner MJ; Raut CP
Arch Surg; 2008 Nov; 143(11):1041-5; discussion 1046. PubMed ID: 19015460
[TBL] [Abstract][Full Text] [Related]
10. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
11. Isomorphic cutaneous graft-versus-host disease reaction after ultraviolet exposure: clinical, histological and direct immunofluorescence studies of four allo-transplanted patients.
Vassallo C; Brazzelli V; Zecca M; Locatelli F; Alessandrino PE; Borroni G
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):913-8. PubMed ID: 19586515
[TBL] [Abstract][Full Text] [Related]
12. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
[TBL] [Abstract][Full Text] [Related]
13. Cystic paracervical mass as an unusual sequela of graft-versus-host disease. A case report.
Gossett DR; Montz FJ; Bristow RE
J Reprod Med; 2002 Jul; 47(7):600-2. PubMed ID: 12170542
[TBL] [Abstract][Full Text] [Related]
14. Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases.
Epstein JB; Gorsky M; Epstein MS; Nantel S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jan; 91(1):56-61. PubMed ID: 11174572
[TBL] [Abstract][Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
16. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease.
Colombo AA; Rusconi C; Esposito C; Bernasconi P; Caldera D; Lazzarino M; Alessandrino EP
Transplantation; 2006 Apr; 81(8):1087-92. PubMed ID: 16641591
[TBL] [Abstract][Full Text] [Related]
17. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
[TBL] [Abstract][Full Text] [Related]
18. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
[TBL] [Abstract][Full Text] [Related]
19. Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation.
Stratton P; Turner ML; Childs R; Barrett J; Bishop M; Wayne AS; Pavletic S
Obstet Gynecol; 2007 Nov; 110(5):1041-9. PubMed ID: 17978118
[TBL] [Abstract][Full Text] [Related]
20. How can we help patients with refractory chronic graft versus host disease- single centre experience.
Rzepecki P; Barzal J; Sarosiek T; Oborska S; Szczylik C
Neoplasma; 2007; 54(5):431-6. PubMed ID: 17688373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
